title: Long-term ranibizumab treatment for choroidal neovascularization secondary to serpiginous choroiditis.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Balaskas
authors.forename: Shafiq
authors.initials: S
authors.lastname: Ur Rehman
authors.forename: Yvonne
authors.initials: Y
authors.lastname: D'Souza
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002833:Choroiditis / Q000150:complications* / Q000503:physiopathology; D005500:Follow-Up Studies; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D000069579:Ranibizumab; D041623:Tomography, Optical Coherence; D017211:Treatment Failure; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab